Craft

NKGen Biotech

Stock Price

$1.5

2024-04-30

Market Capitalization

$34.4 M

2024-04-30

NKGen Biotech Summary

Company Summary

Overview
NKGen Biotech (formerly known as NKMax America) is a biotechnology company that develops cell therapies for neurodegenerative and oncological diseases based on activated NK cells.
Type
Public
Status
Active
Founded
2017
HQ
Santa Ana, CA, US | view all locations
Website
https://nkgenbiotech.com/
Cybersecurity rating
Sectors

Key People

  • Paul Song

    Paul Song, CEO and Chairman

    • Yongman Kim

      Yongman Kim, Chief Scientific Officer

      • James Graf

        James Graf, Interim CFO

        • Paul Chang

          Paul Chang, VP, Development Operations

          LocationsView all

          1 location detected

          • Santa Ana, CA HQ

            United States

            3001 Daimler St

          Footer menu